Funding news - please see here for a statement regarding our current funding situation.
We are an international network of healthcare professionals, researchers and consumers producing systematic reviews of evidence for treating cystic fibrosis and other genetic disorders (haemoglobinopathies. coagulopathies and inborn errors of metabolism). Our editorial base is located in Liverpool, UK.
|Latest output published on The Cochrane Library|
|On Issue 9 2021 of The Cochrane Library we have published a total of 197 reviews and 25 protocols. There are also six registered titles currently progressing to protocol status. The production of these reviews involves a network of over 1000 contributors (authors, consumers and referees) throughout the world. We very much welcome interest from new consumers, referees and potential reviewers. Further information can be obtained by contacting the group.|
By getting involved in these priority-setting partnerships you can help shape future research.
We have already successfully been involved in a priority-setting partnership for CF and you can see the results here. A second iteration of this is now being considered.
A priority-setting partnership has also been undertaken in bleeding disorders; more information can be found here.